Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients

Juan Macías, Karin Neukam, Josep Mallolas, Luis F. López-Cortés, José A. Cartón, Pere Domingo, Santiago Moreno, José A. Iribarren, Bonaventura Clotet, Manell Crespo, Ignacio De Los Santos, Enrique Ortega, Hernando Knobel, María J. Jiménez-Expósito, Juan A. Pineda*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients'. Together they form a unique fingerprint.

Medicine & Life Sciences